10-54329622-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_033056.4(PCDH15):c.679C>T(p.Arg227Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000256 in 1,601,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
PCDH15
NM_033056.4 missense
NM_033056.4 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 5.25
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.751
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH15 | NM_033056.4 | c.679C>T | p.Arg227Cys | missense_variant | 7/33 | ENST00000320301.11 | NP_149045.3 | |
PCDH15 | NM_001384140.1 | c.679C>T | p.Arg227Cys | missense_variant | 7/38 | ENST00000644397.2 | NP_001371069.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.679C>T | p.Arg227Cys | missense_variant | 7/33 | 1 | NM_033056.4 | ENSP00000322604 | ||
PCDH15 | ENST00000644397.2 | c.679C>T | p.Arg227Cys | missense_variant | 7/38 | NM_001384140.1 | ENSP00000495195 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151796Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
151796
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000679 AC: 17AN: 250380Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135330
GnomAD3 exomes
AF:
AC:
17
AN:
250380
Hom.:
AF XY:
AC XY:
6
AN XY:
135330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000234 AC: 34AN: 1449988Hom.: 0 Cov.: 30 AF XY: 0.0000180 AC XY: 13AN XY: 722084
GnomAD4 exome
AF:
AC:
34
AN:
1449988
Hom.:
Cov.:
30
AF XY:
AC XY:
13
AN XY:
722084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151914Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74272
GnomAD4 genome
AF:
AC:
7
AN:
151914
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
Asia WGS
AF:
AC:
1
AN:
3476
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 11, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 227 of the PCDH15 protein (p.Arg227Cys). This variant is present in population databases (rs565693539, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PCDH15-related conditions. ClinVar contains an entry for this variant (Variation ID: 179459). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 09, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 09, 2018 | The p.Arg227Cys variant in PCDH15 has been identified in the heterozygous state in two individuals with hearing loss, one of whom had clinical features of Usher syndrome but was found to have an alternate genetic etiology (LMM data). This v ariant has also been identified in 0.04% (14/34350) of Latino chromosomes by gno mAD (http://gnomad.broadinstitute.org) and has been reported in ClinVar (Variati on ID 179459). Computational prediction tools and conservation analysis do not p rovide strong support for or against an impact to the protein. In summary, the c linical significance of the p.Arg227Cys variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting. - |
Usher syndrome type 1F Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;T;.;.;T;.;T;.;.;T;T;.;.;.;.;.;.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;.;.;.;M;.;.;.;.;.;.;M;.;.;.;.;.;.;.;.;.;M;M
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.;.;.;.;D;D;.;D;.;D;D;.;.;.;D;D;D;.;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;.;.;.;.;.;D;D;.;D;.;D;D;.;.;.;D;D;D;.;D;D;D
Sift4G
Pathogenic
D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0, 1.0, 1.0
.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;.;D;D;D;.;D;D;D
Vest4
MutPred
Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);.;Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);.;Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);.;Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);.;.;Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);.;.;Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);Loss of MoRF binding (P = 0.0662);
MVP
MPC
0.24
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at